Transcatheter Aortic Valve Replacement versus Sutureless Aortic Valve Replacement: A Single Center Retrospective Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study sought to compare clinical outcomes between transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SU-AVR). Materials and Methods: In total, 320 patients with symptomatic severe aortic stenosis who underwent TAVR (n=254) or SU-AVR (n=66) at Severance Cardiovascular Hospital between July 2011 and September 2019 were included for analysis. Propensity score matching and inverse probability weighted adjustment were performed to adjust for confounding baseline characteristics. Outcomes defined by the Valve Academic Research Consortium-2 in 62 patients pairs were compared. Results: Device success (79.0% vs. 79.0%, p>0.999) and 30-day mortality (4.8% vs. 0.0%, p=0.244) did not differ between the TAVR and SU-AVR groups. The TAVR group developed more frequent mild or moderate paravalvular leakage (59.7% vs. 8.1%, p<0.001), whereas SU-AVR was associated with higher rates of major or life-threatening bleeding (9.7% vs. 22.6%, p=0.040), acute kidney injury (8.1% vs. 21.0%, p=0.041), and new-onset atrial fibrillation (4.8% vs. 32.3%. p<0.001) at 30 days, along with longer stays in the intensive care unit (ICU) (1.9±1.6 days vs. 5.9±9.2 days, p=0.009) and hospital (7.1±7.9 days vs. 13.1±8.8 days, p<0.001). The TAVR group showed a trend towards a higher 1-year all-cause mortality, compared with the SU-AVR group (7.0% vs 1.7%, p=0.149). Cardiovascular mortality, however, did not differ significantly (1.6% vs 1.7%, p=0.960). Conclusion: TAVR achieved a similar 1-year survival rate free from cardiovascular mortality as SU-AVR and was associated with a lower incidence of complications, except for paravalvular leakage, and shorter stays in the ICU and hospital.
Abstract
Purpose: This study sought to compare clinical outcomes between transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SU-AVR). Materials and Methods: In total, 320 patients with symptomatic severe aortic stenosis who underwent TAVR (n=254) or SU-AVR (n=66) at Severance Cardiovascular Hospital between July 2011 and September 2019 were included for analysis. Propensity score matching and inverse probability weighted adjustment were performed to adjust for confounding baseline characteristics. Outcomes defined by the Valve Academic Research Consortium-2 in 62 patients pairs were compared. Results: Device success (79.0% vs. 79.0%, p>0.999) and 30-day mortality (4.8% vs. 0.0%, p=0.244) did not differ between the TAVR and SU-AVR groups. The TAVR group developed more frequent mild or moderate paravalvular leakage (59.7% vs. 8.1%, p<0.001), whereas SU-AVR was associated with higher rates of major or life-threatening bleeding (9.7% vs. 22.6%, p=0.040), acute kidney injury (8.1% vs. 21.0%, p=0.041), and new-onset atrial fibrillation (4.8% vs. 32.3%. p<0.001) at 30 days, along with longer stays in the intensive care unit (ICU) (1.9±1.6 days vs. 5.9±9.2 days, p=0.009) and hospital (7.1±7.9 days vs. 13.1±8.8 days, p<0.001). The TAVR group showed a trend towards a higher 1-year all-cause mortality, compared with the SU-AVR group (7.0% vs 1.7%, p=0.149). Cardiovascular mortality, however, did not differ significantly (1.6% vs 1.7%, p=0.960). Conclusion: TAVR achieved a similar 1-year survival rate free from cardiovascular mortality as SU-AVR and was associated with a lower incidence of complications, except for paravalvular leakage, and shorter stays in the ICU and hospital.
참고문헌 (30)
- Danielsen R, "The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades : the AGES-Reykjavík study", Int J Cardiol, 176, pp.916~922 (2014)
- Brennan JM, "Long-term survival after aortic valve replacement among high-risk elderly patients in the United States : insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007", Circulation, 126, pp.1621~1629 (2012)
- Iung B, "Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?", Eur Heart J, 26, pp.2714~2720 (2005)
- Bilkhu R, "Sutureless aortic valve prostheses", Heart, 105, pp.s16~20 (2019)
- Ellouze M, "Sutureless and transcatheter aortic valve replacement : when rivals become allies", Semin Thorac Cardiovasc Surg, 32, pp.427~430 (2019)
- Smith CR, "Transcatheter versus surgical aortic-valve replacement in high-risk patients", N Engl J Med, 364, pp.2187~2198 (2011)
- Adams DH, "Transcatheter aortic-valve replacement with a self-expanding prosthesis", N Engl J Med, 370, pp.1790~1798 (2014)
- Leon MB, "Transcatheter or surgical aortic-valve replacement in intermediate-risk patients", N Engl J Med, 374, pp.1609~1620 (2016)
- Reardon MJ, "Surgical or transcatheter aortic-valve replacement in intermediate-risk patients", N Engl J Med, 376, pp.1321~1331 (2017)
- Mack MJ, "Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients", N Engl J Med, 380, pp.1695~1705 (2019)
- Gilmanov D, "Sutureless implantation of the perceval s aortic valve prosthesis through right anterior minithoracotomy", Ann Thorac Surg, 96, pp.2101~2108 (2013)
- Powell R, "The perceval sutureless aortic valve: review of outcomes, complications, and future direction", Innovations (Phila), 12, pp.155~173 (2017)
- Wang N, "Transcatheter aortic valve implantation(TAVI)versus sutureless aortic valve replacement(SUAVR)for aortic stenosis : a systematic review and meta-analysis of matched studies", J Thorac Dis, 8, pp.3283~3293 (2016)
- Kappetein AP, "Updated standardized endpoint definitions for transcatheter aortic valve implantation : the Valve Academic Research Consortium-2 consensus document(VARC-2)", Eur J Cardiothorac Surg, 42, pp.S45~60 (2012)
- Mehran R, "Standardized bleeding definitions for cardiovascular clinical trials : a consensus report from the Bleeding Academic Research Consortium", Circulation, 123, pp.2736~2747 (2011)
- Kellum JA, "Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury", Kidney Int Suppl, 2, pp.1~138 (2012)
- Siontis GCM, "Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis", Eur Heart J, 40, pp.3143~3153 (2019)
- Lloyd D, "Transcatheter, sutureless and conventional aortic-valve replacement: a network meta-analysis of 16,432 patients", J Thorac Dis, 11, pp.188~199 (2019)
- Sohn SH, "Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: a meta-analysis", J Thorac Cardiovasc Surg, 155, pp.2402-12.e5~ (2018)
- Meco M, "Sutureless aortic valve replacement versus transcatheter aortic valve implantation : a meta-analysis of comparative matched studies using propensity score matching", Interact Cardiovasc Thorac Surg, 26, pp.202~209 (2018)
- Shinn SH, "A systemic review and meta-analysis of sutureless aortic valve replacement versus transcatheter aortic valve implantation", Ann Thorac Surg, 106, pp.924~929 (2018)
- Santarpino G, "Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis : a propensity-matched analysis of 2 strategies in high-risk patients", J Thorac Cardiovasc Surg, 147, pp.561~567 (2014)
- Vasa-Nicotera M, "Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation", JACC Cardiovasc Interv, 5, pp.858~865 (2012)
- Husser O, "Outcomes after transcatheter aortic valve replacement using a novel balloon-expandable transcatheter heart valve : a singlecenter experience", JACC Cardiovasc Interv, 8, pp.1809~1816 (2015)
- Forrest JK, "Early outcomes with the Evolut PRO repositionable selfexpanding transcatheter aortic valve with pericardial wrap", JACC Cardiovasc Interv, 11, pp.160~168 (2018)
- van Boxtel AG, "Postoperative conduction disorders after implantation of the self-expandable sutureless Perceval S bioprosthesis", J Heart Valve Dis, 23, pp.319~324 (2014)
- Mazine A, "Sutureless aortic valve replacement : a Canadian multicentre study", Can J Cardiol, 31, pp.63~68 (2015)
- Rho RW, "The management of atrial fibrillation after cardiac surgery", Heart, 95, pp.422~429 (2009)
- D’Onofrio A, "Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis", J Thorac Cardiovasc Surg, 146, pp.1065~1070 (2013)
- Zaman S, "Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve", Catheter Cardiovasc Interv, 90, pp.147~154 (2017)